Disclosures for "Post-infectious N-methyl-D-aspartate Receptor Encephalitis Antibody Associated with Coxsackie Virus Infection"
-
Dr. Johnson has nothing to disclose.
-
Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celgene. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . The institution of Dr. Obeidat has received research support from Neuroscience research center . The institution of Dr. Obeidat has received research support from Research affairs committee. The institution of Dr. Obeidat has received research support from Center for immunology . The institution of Dr. Obeidat has received research support from Parkinson's foundation . The institution of Dr. Obeidat has received research support from Celgene. The institution of Dr. Obeidat has received research support from BMS. The institution of Dr. Obeidat has received research support from EMD Serono. The institution of Dr. Obeidat has received research support from Genentech . The institution of Dr. Obeidat has received research support from Novartis. The institution of Dr. Obeidat has received research support from NMSS and PCORI. The institution of Dr. Obeidat has received research support from Sanofi. The institution of Dr. Obeidat has received research support from Atara Biotherapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving as a key opinion leader articles with Medscape. Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Advisory Committee Member with ACTRIMS that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities.
-
Dr. Pardhan has nothing to disclose.
-
Dr. Osman has nothing to disclose.
-
Mr. Hommeida has nothing to disclose.
-
Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech/Roche. Dr. Hooshmand has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi .